Cooper Companies (NASDAQ:COO – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.640-3.670 for the period, compared to the consensus EPS estimate of 3.570. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion. Cooper Companies also updated its Q4 guidance to $0.98-1.01 EPS.
Cooper Companies Price Performance
Shares of NASDAQ:COO opened at $105.73 on Friday. The firm has a market capitalization of $21.05 billion, a PE ratio of 62.19, a price-to-earnings-growth ratio of 2.34 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. Cooper Companies has a 52-week low of $75.93 and a 52-week high of $106.95. The firm has a fifty day moving average of $91.53 and a 200 day moving average of $94.19.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.84 EPS. As a group, research analysts anticipate that Cooper Companies will post 3.57 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Cooper Companies
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Stories
- Five stocks we like better than Cooper Companies
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- Using the MarketBeat Stock Split Calculator
- Why Dell Can Continue Winning in AI and Beyond
- What is the Nikkei 225 index?
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.